title: Reducing the burden of disclosure for public biotech companies.
authors.affiliation: Shearman & Sterling LLP, New York, New York, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Evans
authors.affiliation: Shearman & Sterling LLP, New York, New York, USA.
authors.forename: Mark
authors.initials: M
authors.lastname: Kessel
mesh_terms: D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence; D030881:Disclosure; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D017150:Public Sector